Drug Database
Back to search

Finland· FI-REL-REL864

Hiprex

A methenamine product containing methenamine hippurate, registered in Finland by Viatris Oy. The same ATC class is registered in 9 of our 19 countries.

ATC J01XX05

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedHiprexATCJ01XX05REGISTER NO.FI-REL-REL864PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about methenamine hippurateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Methenamine is registered in 9 of 19 countries.

Countries holding a registration under ATC J01XX05 (methenamine), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 4 of them publish a price we can compare per daily dose
Search methenamine products by name

Methenamine · ATC J01XX05

9 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Methenamine hippurate
Manufacturer
Viatris Oy
Country
Finland (FI)
ATC code
J01XX05
ATC class
Methenamine
Defined daily dose
2 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • fi_myyntilupa
    124339
    100
    EUR 31.54

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

22 interactions on record for methenamine.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check methenamine against other medicinesHow interaction checks work

Methenamine · interactions on record

22 records

  • 4 severe
  • 18 moderate

Most severe, free to view

  • SulfasalazineA07EC01severe
  • SulfamethizoleB05CA04severe
  • SulfamethizoleJ01EB02severe
  • SulfasalazinM01CX02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Methenamine in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methenamine products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Belgium · Vesaphir
  • Germany · Cystohipp
  • Denmark · Haiprex, Methenamine Hippurate Eql Pharma
  • France · Altaromin
  • United Kingdom (Northern Ireland) · Hiprex, Methenamine Hippurate Brown & Burk Uk
  • Ireland · Methenamine Hippurate Brown & Burk
  • Iceland · Haiprex
  • Luxembourg · Vesaphir
  • Malta · Methenamine Hippurate Brown & Burk, Methenamine Hippurate Eql Pharma
  • Netherlands · Vesaphir
  • Norway · Hiprex, Methenamine Hippurate Eql Pharma
  • Sweden · Hiprex, Methenamine Hippurate Brown & Burk

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d61635f5-a17d-4a6e-a9c0-7d88abe92d82
GET /v1/drugs/d61635f5-a17d-4a6e-a9c0-7d88abe92d82?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "2",
  "form": "tabletti",
  "route": "Suun kautta",
  "ddd_unit": "g",
  "strength": "1 g",
  "atc_label": "metenamiini",
  "ma_number": "6482",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL864",
  "authorised_at": "1972-12-13"
}
API referenceMCP serverPlans

See everything about methenamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console